The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | G | Genito urinary system and sex hormones | |
2 | G03 | Sex hormones and modulators of the genital system | |
3 | G03F | Progestogens and estrogens in combination | |
4 | G03FB | Progestogens and estrogens, sequential preparations |
Code | Title | |
---|---|---|
G03FB01 | Norgestrel and estrogen | |
G03FB02 | Lynestrenol and estrogen | |
G03FB03 | Chlormadinone and estrogen | |
G03FB04 | Megestrol and estrogen | |
G03FB05 | Norethisterone and estrogen | |
G03FB06 | ||
G03FB07 | Medrogestone and estrogen | |
G03FB08 | Dydrogesterone and estrogen | |
G03FB09 | Levonorgestrel and estrogen | |
G03FB10 | Desogestrel and estrogen | |
G03FB11 | Trimegestone and estrogen |
Title | Information Source | Document Type | |
---|---|---|---|
FEMOSTON Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NOVOFEM Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
PREMPRO Sugar-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
TOTELLE Coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |